Take Care: Patients that use workplace primary care, pharmacy services have higher adherence rates
NEW YORK The findings of the Take Care Health Systems’ survey are important as they undoubtedly underscore the importance of worksite clinics, which are growing increasingly common as U.S. employers look for ways to curb skyrocketing healthcare costs and bolster employee health and productivity.
The study highlights what clinic operators — like Take Care Health Systems with its 300-plus worksite clinics — have known for some time: investing in integrated workplace health and pharmacy programs can, in fact, help employers realize healthcare savings, while improving patient outcomes.
What is the cost savings? As reported in late 2008 by Drug Store News, an August 2008 report by human resources consulting and outsourcing services provider Hewitt Associates, dubbed “Trends in HR and Employee Benefits: Employers Implement On-Site Health Clinics to Manage Costs,” states that some studies suggest that worksite clinics lead to $2 in savings for every $1 invested, and some may even reach $3 to $6 in savings for every $1 invested. Citing data provided by On-Site Health Care, the Hewitt Associates report also states, “For prescription drugs, employers may see 11.9% in brand savings and 56.3% in generic savings.” Then, of course, there’s the issue of medication adherence, which the Take Care Health Systems’ survey clearly addresses. With an estimated price tag of $100 billion, non-adherence is a major drain on the U.S. healthcare system.
Given the results of this study and the trends that are already taking place throughout the convenient care industry, employer-based clinics are something the industry is bound to see on the upswing. In fact, industry sources have suggested that the market could bear as many as 5,000 worksite clinics as the ideal client is an employer with 1,000 or more employees at a site.
McNeil Consumer Healthcare addresses acetaminophen concerns on Tylenol.com
NEW BRUNSWICK, N.J. In the wake of the news around acetaminophen last week, McNeil Consumer Healthcare posted a public letter at www.tylenol.com to explain the news to Tylenol users.
“Recently, there have been reports about acetaminophen, the medicine in Tylenol, and the potential for liver damage if the medicine is misused or taken in overdose amounts,” the letter, signed by Edwin Kuffner, senior medical director, medical affairs at McNeil, opened. “As the makers of Tylenol, we share the FDA’s goal of helping to ensure that over-the-counter and prescription medicines are used safely and properly,” he said. “[But] Tylenol, when taken as directed, remains the safest pain reliever people can take.”
The letter goes on to explain that it’s inappropriate use of acetaminophen products, when patients consume more than the recommended dosage, that is linked to increased liver damage risk.
That message was replicated last week with full-page ads in USAToday, the New York Times and the Wall Street Journal, among other papers.
Isopure Co. to roll out Isopure Plus nationwide
HAUPPAUGE, N.Y. The Isopure Company on Tuesday announced the nationwide rollout of Isopure Plus, a line of clear, protein drinks offering seniors, people with nutritional challenges, and those recovering from weight-loss surgery or medical treatment a clear alternative to thick or milky nutrition drinks, the company stated.
Shipping this fall, Isopure Plus drinks are formulated with 15 grams of whey protein per eight-ounce serving and are available in two flavors — alpine punch and grape frost.
“The revolution in nutrition has begun,” stated Hal Katz, Isopure CEO. “Ready-to-drink nutrition formulas have changed little since they were first introduced more than a decade ago. The market has lost many consumers to taste fatigue and lack of variety. Isopure Plus breaks through the taste and consistency bottleneck and also is perfectly positioned to capitalize on emerging market trends such as an aging population and increased interest in weight-loss surgery.”